The invention relates to a linear polyglycerol compound, comprising a backbone of linearly linked glycerol residues. This compound is characterized in that it carries a plurality of substituents in the nature of covalently bound sulfates, wherein a degree of substitution of the backbone is preferably between 30 and 100%. A method of manufacturing the compound as well as uses of this compound and similar compounds are also disclosed.

Controlled release dosage formulations for the delivery of active agents, especially for treatment of eye diseases or disorders, such as glaucoma, have been developed. These provide release of the active agent, such as ECA or a derivative thereof, for an effective period of time.

Methods of forming, dissolving, and functionalizing an extracellular matrix gel on demand based on cross-linking, modification, and dissolution of hydrogels using transpeptidase (e.g. sortase) are disclosed. Also provided are hydrogels comprising one or more macromers crosslinked to a mixture of peptides, wherein all or a portion of the peptides in the mixture comprise a recognition motif cleavable by a transpeptidase (e.g., sortase).

Provided here are ion conducting materials including one or more macrocycles, and either one or more pendant groups or one or more backbone repeat units. The ion conducting materials exhibit distinctly high ion conductivity in thin film and bulk membrane applications, and further exhibit one or more of ion permselectivity, mechanical strength, self-assembly, stacking, and gating behavior. Further provided are methods for preparation and methods for use of the ion conducting materials.

Provided here are ion conducting materials including one or more macrocycles, and either one or more pendant groups or one or more backbone repeat units. The ion conducting materials exhibit distinctly high ion conductivity in thin film and bulk membrane applications, and further exhibit one or more of ion permselectivity, mechanical strength, self-assembly, stacking, and gating behavior. Further provided are methods for preparation and methods for use of the ion conducting materials.

A heteroatom-containing alkoxy polyether based anionic-nonionic surfactant has the following molecular formula (I):

R.sub.1—O-(Poly).sub.n-X—Y.sup.a−.a/bM.sup.b+  (I).

In formula (I), R.sub.1 is any one of C.sub.1-C.sub.50 aliphatic group and aromatic group; each occurrence of group Poly, equal to or different from each other, is independently selected from the group represented by formula (Ru—O).sub.m; n is a number from greater than 0 to 300; for each type of group (Ru—O), m is independently a number from greater than 0 to 100; X is any one of alkylene, alkenylene and arylene containing 1-10 carbon atoms; Y is an anionic group; and M is a cation or a cationic group.

A hydrophilic polymer derivative having a cyclic benzylidene acetal linker represented by the following formula (1): ##STR00001##
wherein R.sup.1 and R.sup.6 are each independently a hydrogen atom or a hydrocarbon group; R.sup.2, R.sup.3, R.sup.4 and R.sup.5 are each independently an electron-withdrawing or electron-donating substituent or a hydrogen atom; X.sup.1 is a chemically reactive functional group; P is a hydrophilic polymer; s is 1 or 2, t is 0 or 1, and s+t is 1 or 2; w is an integer of 1 to 8; and Z.sup.1 and Z.sup.2 are each independently a selected divalent spacer.

Provided herein are poly-1-hydroxymethylethylene hydroxymethyl formal (PHF)-based drug delivery systems. Also disclosed are methods of making antibody-drug conjugates and methods of treatment using these conjugates.

According to one aspect of the present invention, an organic fluorine compound is represented by a general formula
(R-π-E-CH.sub.2-A-CH.sub.2-E′).sub.n-π′-G  (1B) (where n is an integer of 2 to 5, A is a divalent perfluoropolyether group, π is an arylene group or a single bond, R is an alkenyl group or an alkynyl group, and E and E′ are each independently an ether bond or an ester bond or a group that is represented by a chemical formula
—O—CH.sub.2CH(OH)CH.sub.2O—
π′ is a group in which n+1 hydrogen atoms are separated from benzene, G is an organic group containing a fullerene skeleton, the n number of groups each of which is represented by a general formula
R-π-E-CH.sub.2-A-CH.sub.2-E′-
may be the same or different, and at least one π among the n number of π is an arylene group).

The present invention relates to a technique for effective intranasal delivery to the brain. More specifically, the present invention is used for diagnosing, preventing or treating central nervous system encephalopathy, neurodegenerative diseases or brain tumor by effectively delivering to the brain a pH-responsive and bioreducible PPA polymer, which can be used as a drug carrier, by means of nasal administration.